Advertisement
Screener

Clovis Oncology, Inc. Form PRER14A: Revised preliminary proxy statement

Clovis Oncology, Inc. Form PRER14A: Revised preliminary proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2019-04-24: Form PRER14A; Description PRER14A; Document d668722dprer14a.htm.
FiledFormPeriod of reportDescriptionDocument
2019-04-24PRER14APRER14Ad668722dprer14a.htm